05-15-2021, 07:30 PM
it's essential to approach discussions on prognosis with sensitivity, as it can be a difficult topic for patients and their cherished ones. While phase 4 lung cancer is associated with a decrease survival rate, advances in treatment alternatives, including qualified therapies and immunotherapy, have improved outcomes for any patients.